Ultralife Corp. Reports Impressive Growth in 2023 Annual Report
Ultralife Corp. (NASDAQ: ULBI), a prominent provider of advanced power solutions and communication systems, has released its annual report for the fiscal year ending December 31, 2023. The report highlights significant growth in revenue, improved profitability, and strategic advancements that solidify the company's position in the government, defense, and commercial sectors.
1. Revenue Growth
Ultralife Corp. reported consolidated revenues of $158.64 million for 2023, reflecting a remarkable increase of 20.3% from $131.84 million in 2022. This growth was primarily driven by strong sales across both commercial and government sectors, with government and defense sales surging by 49.0% to $57.80 million, while commercial sales increased by 8.4% to $100.80 million.
Geographic Performance
Sales in the United States accounted for a substantial portion of total revenue, totaling $81.39 million, up 19.85% from $67.91 million in the previous year. Non-U.S. revenues also saw a robust increase of 20.84%, reaching $77.24 million compared to $63.92 million in 2022, showcasing Ultralife's expanding global footprint.
Segment Analysis
Ultralife's revenue is segmented into two primary categories: Battery & Energy Products and Communications Systems. The Battery & Energy Products segment generated $129.90 million in 2023, a growth of 8.3% from the previous year, while the Communications Systems segment witnessed an impressive 142.22% increase, reaching $28.69 million, up from $11.84 million in 2022.
2. Financial Performance
Ultralife's financial performance reflects a robust recovery from the prior year. The company reported a net income of $7.19 million for 2023, a marked turnaround from a net loss of $119,000 in 2022. This shift highlights Ultralife's effective management and strategic initiatives during the year.
Improved Gross Margin
The company's gross margin improved significantly, rising to 24.7% from 22.3% in 2022. This increase was attributed to better alignment of customer price increases with the inflation of raw material costs, enhanced production processes, and concerted efforts in new product development.
Operating Expenses and Other Income
Operating expenses increased modestly by 1.6% to $29.73 million, reflecting the company's continued investment in new product development and cybersecurity measures. Notably, other expenses decreased to $358,000, primarily due to an Employee Retention Credit that provided financial relief during the year.
3. Cash Flow and Balance Sheet Strength
Ultralife's financial health is further demonstrated through its improved cash position. The company reported a net cash increase of $4.56 million, resulting in a cash balance of $10.28 million as of December 31, 2023. The cash flow from operating activities also turned positive, generating $1.93 million compared to a cash outflow in 2022.
Balance Sheet Overview
As of December 31, 2023, Ultralife's total assets stood at $174.5 million, with total liabilities amounting to $52.84 million. The balance sheet reflects a stable capital structure with total equity of $125.4 million, showcasing Ultralife's solid foundation for future growth.
| Mar 2023 | Mar 2024 | |
|---|---|---|
Total Assets | 166.1M | 174.5M |
Total Current Assets | 78.98M | 90.20M |
Cash and Equivalents | 5.71M | 10.27M |
Net Inventories | 41.19M | 42.21M |
Accounts Receivable | 27.77M | 31.76M |
Prepaid Expenses | 4.30M | 5.94M |
Total Non-current Assets | 87.13M | 84.36M |
Intangible Assets | 53.34M | 52.67M |
Non-current Deferred Tax Assets | 12.06M | 10.56M |
Net PP&E | 21.71M | 21.11M |
Total Liabilities and Equity | 168.4M | 178.2M |
Total Liabilities | 52.02M | 52.84M |
Total Current Liabilities | 28.91M | 23.73M |
Accounts Payable and Accrued Liabilities | 18.96M | 14.45M |
Current Debt | 2M | 2M |
Other Current Liabilities | 7.94M | 7.27M |
Total Non-current Liabilities | 23.11M | 29.11M |
Long-term Debt | 19.31M | 23.62M |
Non-current Deferred Tax Liabilities | 1.91M | 1.71M |
Other Non-current Liabilities | 1.88M | 3.78M |
Total Equity and Non-controlling Interests | 116.4M | 125.4M |
Total Equity | 116.2M | 125.3M |
Non-controlling Interests | 126K | 95K |
| Mar 2023 | Mar 2024 | |
|---|---|---|
Net Income | -119K | 7.19M |
Net Income to Non-controlling Interest | -1K | -31K |
Profit | -120K | 7.16M |
Net Income Continuing | -120K | 7.16M |
Income Tax Expense | -326K | 1.95M |
Pretax Income | -446K | 9.11M |
Non-operating Income | -575K | -358K |
Operating Income | 129K | 9.47M |
Revenue | 131.8M | 158.6M |
Costs and Expenses | 131.7M | 149.1M |
Cost of Revenue | 102.4M | 119.4M |
Operating Expenses | 29.27M | 29.72M |
Research & Development | 7.08M | 7.53M |
Selling, General & Administrative | 22.19M | 22.19M |
| Mar 2023 | Mar 2024 | |
|---|---|---|
Net Change in Cash | -2.7M | 4.56M |
Effect of Exchange Rate Changes | -276K | -302K |
Net Cash from Operating Activities | -1.26M | 1.92M |
Operating Profit | -120K | 7.16M |
Adjustment to Operating Profit | -1.14M | -5.23M |
Net Cash from Investing Activities | -1.67M | -2.55M |
Productive Assets | 1.67M | 2.55M |
Net Cash from Financing Activities | 518K | 5.49M |
Debt | 517K | 4.25M |
Equity Issuance/Repurchase | 116K | 1.24M |
Other Financing Activities | -115K | -8K |
4. Strategic Focus and Future Outlook
Ultralife Corp. continues to prioritize strategic acquisitions to enhance its product offerings and market presence. The company remains well-positioned to capitalize on the growing demand for advanced power solutions and communication systems, particularly in government and defense sectors.
With a focus on innovation, operational efficiency, and expanding into new markets, Ultralife aims to sustain its growth trajectory and deliver value to its shareholders.
5. Conclusion
The 2023 annual report underscores Ultralife Corp.'s successful turnaround and robust financial performance. As the company continues to navigate the evolving landscape of power solutions and communication systems, investors can expect Ultralife to maintain its commitment to growth and innovation in the years ahead.
